Trial intelligence / Profile preview

Bupropion vs Bupropion + Naltrexone for Smoking Cessation

NCT00419731Phase 3Unknown

Sponsor
University of Minnesota
Start
Nov 2006
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of naltrexone in Tobacco Use Disorder (TUD), sponsored by University of Minnesota. Status: unknown.

02

Drugs

naltrexone
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00419731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call